Literature DB >> 8004809

Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.

M Kemp1, A S Hey, J A Kurtzhals, C B Christensen, A Gaafar, M D Mustafa, A A Kordofani, A Ismail, A Kharazmi, T G Theander.   

Abstract

The T cell response to antigens from Leishmania major promastigotes was investigated in peripheral blood mononuclear cells from Sudanese individuals with a history of cutaneous leishmaniasis (CL), Sudanese individuals with positive DTH reaction in the leishmanin skin test but with no history of skin lesions, and in Danes without known exposure to Leishmania parasites. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in antigen-stimulated cultures was measured. Lymphocytes from individuals with a history of CL proliferated vigorously and produced IFN-gamma after stimulation with either a crude preparation of L. major antigens or the major surface protease gp63. These cultures produced no or only little IL-4. Also cells from leishmanin skin test-positive donors with no history of CL produced IFN-gamma and no IL-4 in response to L. major antigens. Cells from the unexposed Danes were not activated by gp63. The cells from Danish donors produced either IFN-gamma or IL-4, but not both cytokines after incubation with the crude preparation of L. major antigens. The data show that the T cell response to Leishmania antigens in humans who have had uncomplicated CL or subclinical L. major infection is an IFN-gamma-producing Th1-like response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004809      PMCID: PMC1534571          DOI: 10.1111/j.1365-2249.1994.tb06043.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis.

Authors:  S Pampiglione; P E Manson-Bahr; F Giungi; G Giunti; A Parenti; G Canestri Trotti
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

2.  Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes.

Authors:  J Bouvier; R J Etges; C Bordier
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

3.  An analysis of T cell responsiveness in Indian kala-azar.

Authors:  D L Sacks; S L Lal; S N Shrivastava; J Blackwell; F A Neva
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

4.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

6.  Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma.

Authors:  D L Hoover; C A Nacy; M S Meltzer
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

7.  Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.

Authors:  D G Russell; J Alexander
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

8.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.

Authors:  C A Nacy; A H Fortier; M S Meltzer; N A Buchmeier; R D Schreiber
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.

Authors:  J A Kurtzhals; A S Hey; A Jardim; M Kemp; K U Schaefer; E O Odera; C B Christensen; J I Githure; R W Olafson; T G Theander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more
  17 in total

1.  Diagnostic techniques to detect cryptic leishmaniasis in dogs.

Authors:  Laura Iniesta; Salceda Fernández-Barredo; Béatrice Bulle; M Teresa Gómez; Renaud Piarroux; Montserrat Gállego; José M Alunda; Montserrat Portús
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.

Authors:  A Sassi; H Louzir; A Ben Salah; M Mokni; A Ben Osman; K Dellagi
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.

Authors:  K Maasho; F Sanchez; E Schurr; A Hailu; H Akuffo
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 4.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.

Authors:  K Kemp; M Kemp; A Kharazmi; A Ismail; J A Kurtzhals; L Hviid; T G Theander
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

6.  Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production.

Authors:  J Li; S Sutterwala; J P Farrell
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.

Authors:  S Farajnia; F Mahboudi; S Ajdari; N E Reiner; A Kariminia; M H Alimohammadian
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

8.  Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

Authors:  S Ajdary; M H Alimohammadian; M B Eslami; K Kemp; A Kharazmi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.

Authors:  Mohammad H Alimohammadian; Stephen L Jones; Haideh Darabi; Farhad Riazirad; Soheila Ajdary; Aliakbar Shabani; Mohammad A Rezaee; Mehdi Mohebali; Zohreh Hosseini; Farrokh Modabber
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

10.  CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.

Authors:  R Jafari-Shakib; S Ajdary; Z Mohtasham Amiri; A M Mohammadi; K Nourijelyani; H Mortazavi; M A Shokrgozar; B Nikbin; A Khamesipour
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.